Archived news

2008

Search for

EuroGenGuide website launchedThe EC-funded project EuroGenGuide has been launched to provide a 'onestop' resource for European patients and health professionals concerned about genetic testing and research. 04 December 2008
EAASM December 2008 newsletter 03 December 2008
Patient Link Workshop focuses on “The power of partnering”The workshop brought together representatives from 35 European associations that support patients with neurological disorders. 13 November 2008
Attempt to beat the Round-the-World Cycle Time-RecordIn April 2009, James Bowthorpe will set off from London in an attempt to break the world record for cycling around the globe, with the intention of raising £1.8 million for Parkinson's research. 12 November 2009
An interview with Janet Hamburg, producer of the Motivating Moves for People With Parkinson's DVDMotivating Moves is an approach to exercise that emphasizes coordination, balance, flexibility, postural alignment, diaphragmatic breathing, spatial awareness and dynamic movement range. 23 October 2008
6 and 8 mg/24h strengths of Neupro® (rotigotine transdermal patch) to be available again in [UK] pharmacies from 10th November 2In June, a notice regarding storage of Neupro® (rotigotine transdermal patch) in a refrigerator was issued by the EMEA following UCB's recall of certain batches of Neupro®. This recall affected all Neupro® products still remaining in the distribution chain which was to be replaced with refrigerated Neupro® and that to this effect, the market would only be supplied with the 2 and 4 mg/24h patches for an interim period. 22 October 2008
European project to carry out a technology and foresight analysis of assistive technologiesThe European project MARE aims at working closely with users and experts in carrying out a technology and foresight analysis in the field of Assistive Technologies (AT). 20 October 2008
EAASM October 2008 newsletter 09 October 2008
AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy PlatfoAmsterdam Molecular Therapeutics (Euronext: AMT) today announced that it obtained a license from Amgen to use their GDNF gene for the development of a gene therapy treatment for Parkinson's disease. 18 September 2008
New Voice Aerobics™ DVD for people with voice, speech, and swallowing problemsPunta Gorda, Florida, September 16, 2008 - Nearly ninety percent of people with Parkinson's disease develop a voice, speech, or swallowing problem. 16 September 2008

Page: [1] [2] [3] [4]

[ Next » ]